Value proposition

Liquid biopsies with cell-free RNA. A revolutionary tool for diagnosis, prognosis and patient stratification.

Flomics is developing novel blood-based diagnostic tools for a broad range of complex diseases. Our proprietary technology accurately identifies pattern changes in the circulating long RNA molecules of patients. With deep learning algorithms we identify RNA changes associated with disease states in a faster, cheaper and non-invasive way.


transcriptomics, circulating RNA, liquid biopsies, fluids transcriptomics, artificial intelligence, genome, diagnostics, and genomics